Clinical trial
Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study With Pentoxifylline
NCT07086794 is registered in ClinicalTrials.gov with William Stoops as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Immune Inflammation in Cocaine Use Disorder: A Human Laboratory Study With Pentoxifylline
- Lead sponsor
- William Stoops
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- November 10, 2025
- Completion date
- February 28, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cocaine use disorder